mesenchymal stem cells, haploidentical (bone marrow-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mesenchymal stem cells, haploidentical (bone marrow-derived), covering 2019-11-08 to 2019-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]